Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year after Kidney Transplantation.

Marques IDB, Araújo MJCLN, Graciolli FG, Dos Reis LM, Pereira RMR, Alvarenga JC, Custódio MR, Jorgetti V, Elias RM, Moysés RMA, David-Neto E.

J Am Soc Nephrol. 2019 Jan 3. pii: ASN.2018060656. doi: 10.1681/ASN.2018060656. [Epub ahead of print]

PMID:
30606784
2.

Corrigendum to "Quality of life after surgery in secondary hyperparathyroidism comparing subtotal parathyroidectomy to total parathyroidectomy with immediate parathyroid autograft - a prospective randomized trial" [Surgery 164 (2018) 978-985].

Filho WA, van der Plas WY, Brescia MDG, Nascimento CP Jr, Goldenstein PT, Neto LMM, Arap SS, Custodio MR, Bueno RO, Moyses RMA, Jorgetti V, Kruijff S, Montenegro FLM.

Surgery. 2019 Feb;165(2):497. doi: 10.1016/j.surg.2018.11.010. Epub 2018 Nov 28. No abstract available.

PMID:
30501922
3.

Is arterial calcification in children and adolescents with end stage renal disease a rare finding?

de Menezes FL, Koch-Nogueira PC, do Val MLDM, Pestana JOM, Jorgetti V, Dos Reis MA, Dos Reis Monteiro MLG, Leite HP.

Nephrology (Carlton). 2018 Aug 26. doi: 10.1111/nep.13480. [Epub ahead of print]

PMID:
30146772
4.

The unexpected presence of iron in bone biopsies of hemodialysis patients.

Custodio MR, Elias RM, Velasquez WD, Dos Reis LM, Oliveira IB, Moysés RMA, Carvalho AB, Jorgetti V.

Int Urol Nephrol. 2018 Oct;50(10):1907-1912. doi: 10.1007/s11255-018-1936-4. Epub 2018 Aug 22.

PMID:
30136087
5.

The trabecular bone score: Relationships with trabecular and cortical microarchitecture measured by HR-pQCT and histomorphometry in patients with chronic kidney disease.

Ramalho J, Marques IDB, Hans D, Dempster D, Zhou H, Patel P, Pereira RMR, Jorgetti V, Moyses RMA, Nickolas TL.

Bone. 2018 Nov;116:215-220. doi: 10.1016/j.bone.2018.08.006. Epub 2018 Aug 8.

PMID:
30098418
6.

Quality of life after surgery in secondary hyperparathyroidism, comparing subtotal parathyroidectomy with total parathyroidectomy with immediate parathyroid autograft: Prospective randomized trial.

Filho WA, van der Plas WY, Brescia MDG, Nascimento CP Jr, Goldenstein PT, Neto LMM, Arap SS, Custodio MR, Bueno RO, Moyses RMA, Jorgetti V, Kruijf S, Montenegro FLM.

Surgery. 2018 Nov;164(5):978-985. doi: 10.1016/j.surg.2018.06.032. Epub 2018 Aug 3. Erratum in: Surgery. 2019 Feb;165(2):497.

PMID:
30082137
7.

A prospective study of the influence of the skeleton on calcium mass transfer during hemodialysis.

Goldenstein PT, Graciolli FG, Antunes GL, Dominguez WV, Dos Reis LM, Moe S, Elias RM, Jorgetti V, Moysés RMA.

PLoS One. 2018 Jul 30;13(7):e0198946. doi: 10.1371/journal.pone.0198946. eCollection 2018.

8.

The enigma of aluminum deposition in bone tissue from a patient with chronic kidney disease: a case report.

Meira RD, Carbonara CEM, Quadros KRDS, Santos CUD, Schincariol P, Pêssoa GS, Arruda MAZ, Jorgetti V, Oliveira RB.

J Bras Nefrol. 2018 Apr-Jun;40(2):201-205. doi: 10.1590/2175-8239-JBN-3882. Epub 2018 Jun 4. English, Portuguese.

9.

The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: A post hoc analysis.

Hernandez MJ, Dos Reis LM, Marques ID, Araujo MJ, Truyts CAM, Oliveira IB, Barreto FC, David-Neto E, Custodio MR, Moyses RM, Bellorin-Font E, Jorgetti V.

PLoS One. 2018 May 25;13(5):e0197994. doi: 10.1371/journal.pone.0197994. eCollection 2018.

10.

Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.

de Castro BBA, do Carmo WB, de Albuquerque Suassuna PG, Carminatti M, Brito JB, Dominguez WV, de Oliveira IB, Jorgetti V, Custodio MR, Sanders-Pinheiro H.

Exp Biol Med (Maywood). 2018 May;243(9):796-802. doi: 10.1177/1535370218775035.

PMID:
29763365
11.

Time to rethink the use of bone biopsy to prevent fractures in patients with chronic kidney disease.

Steller Wagner Martins C, Jorgetti V, Moysés RMA.

Curr Opin Nephrol Hypertens. 2018 Jul;27(4):243-250. doi: 10.1097/MNH.0000000000000418.

PMID:
29608453
12.

Dialysis as a Treatment Option for a Patient With Normal Kidney Function and Familial Tumoral Calcinosis Due to a Compound Heterozygous FGF23 Mutation.

Goldenstein PT, Neves PD, Balbo BE, Elias RM, Pereira AC, Onuchic LF, Jüppner H, Jorgetti V, Abensur H, Moysés RM.

Am J Kidney Dis. 2018 Sep;72(3):457-461. doi: 10.1053/j.ajkd.2017.12.020. Epub 2018 Mar 14.

13.

Comparison of clinical, biochemical and histomorphometric analysis of bone biopsies in dialysis patients with and without fractures.

Santos MFP, Hernández MJ, de Oliveira IB, Siqueira FR, Dominguez WV, Dos Reis LM, Carvalho AB, Moysés RMA, Jorgetti V.

J Bone Miner Metab. 2018 Jan 25. doi: 10.1007/s00774-018-0902-7. [Epub ahead of print]

PMID:
29372334
14.

Effect of variations in dietary Pi intake on intestinal Pi transporters (NaPi-IIb, PiT-1, and PiT-2) and phosphate-regulating factors (PTH, FGF-23, and MEPE).

Aniteli TM, de Siqueira FR, Dos Reis LM, Dominguez WV, de Oliveira EMC, Castelucci P, Moysés RMA, Jorgetti V.

Pflugers Arch. 2018 Apr;470(4):623-632. doi: 10.1007/s00424-018-2111-6. Epub 2018 Jan 25.

PMID:
29372301
15.

Persistent hyperparathyroidism as a risk factor for long-term graft failure: the need to discuss indication for parathyroidectomy.

Araujo MJCLN, Ramalho JAM, Elias RM, Jorgetti V, Nahas W, Custodio M, Moysés RMA, David-Neto E.

Surgery. 2018 May;163(5):1144-1150. doi: 10.1016/j.surg.2017.12.010. Epub 2018 Jan 10.

PMID:
29331397
16.

Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism.

Albuquerque RFC, Carbonara CEM, Martin RCT, Dos Reis LM, do Nascimento CP Júnior, Arap SS, Moysés RMA, Jorgetti V, Montenegro FLM, de Oliveira RB.

Surgery. 2018 Feb;163(2):381-387. doi: 10.1016/j.surg.2017.09.005. Epub 2017 Nov 13.

PMID:
29146232
17.

Hypovitaminosis D in patients undergoing kidney transplant: the importance of sunlight exposure.

Vilarta CF, Unger MD, Dos Reis LM, Dominguez WV, David-Neto E, Moysés RM, Titan S, Custodio MR, Hernandez MJ, Jorgetti V.

Clinics (Sao Paulo). 2017 Jul;72(7):415-421. doi: 10.6061/clinics/2017(07)05.

18.

Renal osteodystrophy in the obesity era: Is metabolic syndrome relevant?

Da Silva Martins J, Castro JH, Sainz Rueda NA, Dos Reis LM, Jorgetti V, Affonso Moysés RM, Caramori JT.

PLoS One. 2017 Jul 18;12(7):e0180387. doi: 10.1371/journal.pone.0180387. eCollection 2017.

19.

Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment.

Spirlandeli AL, Dick-de-Paula I, Zamarioli A, Jorgetti V, Ramalho LNZ, Nogueira-Barbosa MH, Volpon JB, Jordão AA, Cunha FQ, Fukada SY, de Paula FJA.

Clinics (Sao Paulo). 2017 Apr;72(4):231-237. doi: 10.6061/clinics/2017(04)07.

20.

Early postoperative parathormone sampling and prognosis after total parathyroidectomy in secondary hyperparathyroidism.

Nascimento CPD Júnior, Brescia MDG, Custódio MR, Massoni LM Neto, Silveira AA, Goldenstein PT, Arap SS, Jorgetti V, Moyses RMA, Montenegro FLM.

J Bras Nefrol. 2017 Apr-Jun;39(2):135-140. doi: 10.5935/0101-2800.20170021. Epub 2017 Apr 27. English, Portuguese.

21.

The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.

Graciolli FG, Neves KR, Barreto F, Barreto DV, Dos Reis LM, Canziani ME, Sabbagh Y, Carvalho AB, Jorgetti V, Elias RM, Schiavi S, Moysés RMA.

Kidney Int. 2017 Jun;91(6):1436-1446. doi: 10.1016/j.kint.2016.12.029. Epub 2017 Mar 18.

PMID:
28318623
22.

Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities.

Marques ID, Araújo MJ, Graciolli FG, Reis LM, Pereira RM, Custódio MR, Jorgetti V, Elias RM, David-Neto E, Moysés RM.

Osteoporos Int. 2017 May;28(5):1675-1683. doi: 10.1007/s00198-017-3956-9. Epub 2017 Feb 16.

PMID:
28204954
23.

Serum levels of fibroblast growth factor 23 are elevated in patients with active Lupus nephritis.

Resende AL, Elias RM, Wolf M, Dos Reis LM, Graciolli FG, Santos GD, Dias CB, Jorgetti V, Woronik V, Moysés RM.

Cytokine. 2017 Mar;91:124-127. doi: 10.1016/j.cyto.2016.12.022. Epub 2017 Jan 4.

PMID:
28063327
24.

Predictive Factors of One-Year Mortality in a Cohort of Patients Undergoing Urgent-Start Hemodialysis.

Magalhães LP, Dos Reis LM, Graciolli FG, Pereira BJ, de Oliveira RB, de Souza AA, Moyses RM, Elias RM, Jorgetti V.

PLoS One. 2017 Jan 3;12(1):e0167895. doi: 10.1371/journal.pone.0167895. eCollection 2017.

25.

The deceptive concept of hypoparathyroidism and recurrence after parathyroidectomy in dialysis patients: are we offering a Procrustean bed to some patients?

Montenegro FL, Brescia MD, Nascimento CP Júnior, Massoni LM Neto, Arap SS, Santos SR, Goldenstein PT, Bueno RO, Custodio MR, Jorgetti V, Moyses RM.

Rev Col Bras Cir. 2016 Sep-Oct;43(5):327-333. doi: 10.1590/0100-69912016005002. English, Portuguese.

26.

Fragility Fracture Incidence in Chronic Obstructive Pulmonary Disease (COPD) Patients Associates With Nanoporosity, Mineral/Matrix Ratio, and Pyridinoline Content at Actively Bone-Forming Trabecular Surfaces.

Paschalis EP, Gamsjaeger S, Dempster D, Jorgetti V, Borba V, Boguszewski CL, Klaushofer K, Moreira CA.

J Bone Miner Res. 2017 Jan;32(1):165-171. doi: 10.1002/jbmr.2933. Epub 2016 Oct 31.

27.

Vitamin K plasma levels determination in human health.

Fusaro M, Gallieni M, Rizzo MA, Stucchi A, Delanaye P, Cavalier E, Moysés RMA, Jorgetti V, Iervasi G, Giannini S, Fabris F, Aghi A, Sella S, Galli F, Viola V, Plebani M.

Clin Chem Lab Med. 2017 May 1;55(6):789-799. doi: 10.1515/cclm-2016-0783. Review.

28.

The pitfall of treating low bone turnover: Effects on cortical porosity.

Araujo MJ, Karohl C, Elias RM, Barreto FC, Barreto DV, Canziani ME, Carvalho AB, Jorgetti V, Moyses RM.

Bone. 2016 Oct;91:75-80. doi: 10.1016/j.bone.2016.07.009. Epub 2016 Jul 15.

PMID:
27424935
29.

Parathyroidectomy Improves Restless Leg Syndrome in Patients on Hemodialysis.

Santos RS, Coelho FM, da Silva BC, Graciolli FG, Dominguez WV, de Menezes Montenegro FL, Jorgetti V, Moysés RM, Elias RM.

PLoS One. 2016 May 19;11(5):e0155835. doi: 10.1371/journal.pone.0155835. eCollection 2016.

30.

Histomorphometric bone assessment in patients with fracture of the proximal end of the femur.

de Souza CG, de Souza MP, Jorgetti V, Dos Reis LM.

Acta Ortop Bras. 2015 Mar-Apr;23(2):103-6. doi: 10.1590/1413-78522015230201056.

31.

Histomorphometric analysis of the femoral neck in patients with and without femoral neck fracture.

de Souza CG, Jorgetti V, Dos Reis LM, Croci AT.

Acta Ortop Bras. 2015 Mar-Apr;23(2):98-102. doi: 10.1590/1413-78522015230201055.

32.

Role of proton receptor OGR1 in bone response to metabolic acidosis?

Jorgetti V, Drüeke TB, Ott SM.

Kidney Int. 2016 Mar;89(3):529-31. doi: 10.1016/j.kint.2015.12.031.

PMID:
26880446
33.

1,25-Dihydroxyvitamin D Alone Improves Skeletal Growth, Microarchitecture, and Strength in a Murine Model of XLH, Despite Enhanced FGF23 Expression.

Liu ES, Martins JS, Raimann A, Chae BT, Brooks DJ, Jorgetti V, Bouxsein ML, Demay MB.

J Bone Miner Res. 2016 May;31(5):929-39. doi: 10.1002/jbmr.2783. Epub 2016 Feb 2.

34.

Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.

Sprague SM, Bellorin-Font E, Jorgetti V, Carvalho AB, Malluche HH, Ferreira A, D'Haese PC, Drüeke TB, Du H, Manley T, Rojas E, Moe SM.

Am J Kidney Dis. 2016 Apr;67(4):559-66. doi: 10.1053/j.ajkd.2015.06.023. Epub 2015 Aug 25.

PMID:
26321176
35.

Pregnancy and Lactation-Associated Osteoporosis: Bone Histomorphometric Analysis and Response to Treatment with Zoledronic Acid.

Grizzo FM, da Silva Martins J, Pinheiro MM, Jorgetti V, Carvalho MD, Pelloso SM.

Calcif Tissue Int. 2015 Oct;97(4):421-5. doi: 10.1007/s00223-015-0028-z. Epub 2015 Jun 25.

PMID:
26108650
36.

Peritoneal delivery of sodium pyrophosphate blocks the progression of pre-existing vascular calcification in uremic apolipoprotein-E knockout mice.

de Oliveira RB, Louvet L, Riser BL, Barreto FC, Benchitrit J, Rezg R, Poirot S, Jorgetti V, Drüeke TB, Massy ZA.

Calcif Tissue Int. 2015 Aug;97(2):179-92. doi: 10.1007/s00223-015-0020-7. Epub 2015 Jun 19.

PMID:
26087714
37.

Subtle changes in bone mineralization density distribution in most severely affected patients with chronic obstructive pulmonary disease.

Misof BM, Roschger P, Jorgetti V, Klaushofer K, Borba VZ, Boguszewski CL, Cohen A, Shane E, Zhou H, Dempster DW, Moreira CA.

Bone. 2015 Oct;79:1-7. doi: 10.1016/j.bone.2015.05.018. Epub 2015 May 21.

PMID:
26003953
38.

Exercise training, creatine supplementation, and bone health in ovariectomized rats.

Murai IH, Roschel H, Pabis LV, Takayama L, de Oliveira RB, Dos Santos Pereira RT, Dantas WS, Pereira RM, Jorgetti V, Ballester RY, Gualano B.

Osteoporos Int. 2015 Apr;26(4):1395-404. doi: 10.1007/s00198-014-3017-6. Epub 2015 Jan 14.

PMID:
25586761
39.

Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease.

de Oliveira RA, Barreto FC, Mendes M, dos Reis LM, Castro JH, Britto ZM, Marques ID, Carvalho AB, Moysés RM, Jorgetti V.

Kidney Int. 2015 May;87(5):1039-45. doi: 10.1038/ki.2014.372. Epub 2014 Dec 10.

PMID:
25493951
40.

Serum sclerostin is an independent predictor of mortality in hemodialysis patients.

Gonçalves FL, Elias RM, dos Reis LM, Graciolli FG, Zampieri FG, Oliveira RB, Jorgetti V, Moysés RM.

BMC Nephrol. 2014 Dec 2;15:190. doi: 10.1186/1471-2369-15-190.

41.

Brazilian Registry of Bone Biopsy (REBRABO): design, data elements and methodology.

de Oliveira RB, Barreto FC, Custódio MR, Gueiros JE, Neves CL, Karohl C, Sampaio Ede A, da Costa RM, Canziani ME, Moysés RM, de Carvalho AB, Jorgetti V.

J Bras Nefrol. 2014 Jul-Sep;36(3):352-9. English, Portuguese.

42.

Bone disease in newly diagnosed lupus nephritis patients.

Resende AL, dos Reis LM, Dias CB, Custódio MR, Jorgetti V, Woronik V.

PLoS One. 2014 Sep 17;9(9):e106728. doi: 10.1371/journal.pone.0106728. eCollection 2014.

43.

Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5/6 nephrectomy and adenine models.

Ferrari GO, Ferreira JC, Cavallari RT, Neves KR, dos Reis LM, Dominguez WV, Oliveira EC, Graciolli FG, Passlick-Deetjen J, Jorgetti V, Moysés RM.

BMC Nephrol. 2014 May 3;15:69. doi: 10.1186/1471-2369-15-69.

44.

Expression of fibroblast growth factor 23, vitamin D receptor, and sclerostin in bone tissue from hypercalciuric stone formers.

Menon VB, Moysés RM, Gomes SA, de Carvalho AB, Jorgetti V, Heilberg IP.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1263-70. doi: 10.2215/CJN.10030913. Epub 2014 Apr 24.

45.

Is bone transplantation the gold standard for repair of alveolar bone defects?

Raposo-Amaral CE, Bueno DF, Almeida AB, Jorgetti V, Costa CC, Gouveia CH, Vulcano LC, Fanganiello RD, Passos-Bueno MR, Alonso N.

J Tissue Eng. 2014 Jan 16;5:2041731413519352. doi: 10.1177/2041731413519352. eCollection 2014.

46.

Effects of pyrophosphate delivery in a peritoneal dialysis solution on bone tissue of apolipoprotein-E knockout mice with chronic kidney disease.

Barreto FC, de Oliveira RB, Benchitrit J, Louvet L, Rezg R, Poirot S, Jorgetti V, Drüeke TB, Riser BL, Massy ZA.

J Bone Miner Metab. 2014 Nov;32(6):636-44. doi: 10.1007/s00774-013-0541-y. Epub 2014 Jan 21.

PMID:
24442863
47.

[Clinical protocol and therapeutic guidelines for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease].

Custódio MR, Canziani ME, Moysés RM, Barreto FC, Neves CL, de Oliveira RB, Karohl C, Sampaio Ede A, Gueiros JE, Jorgetti V, de Carvalho AB.

J Bras Nefrol. 2013 Oct-Dec;35(4):308-22. doi: 10.5935/0101-2800.20130050. Portuguese. No abstract available.

48.

Ethnic differences in bone and mineral metabolism in healthy people and patients with CKD.

Jorgetti V, dos Reis LM, Ott SM.

Kidney Int. 2014 Jun;85(6):1283-9. doi: 10.1038/ki.2013.443. Epub 2013 Dec 18. Review.

49.

Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease--role of sclerostin?

Ferreira JC, Ferrari GO, Neves KR, Cavallari RT, Dominguez WV, Dos Reis LM, Graciolli FG, Oliveira EC, Liu S, Sabbagh Y, Jorgetti V, Schiavi S, Moysés RM.

PLoS One. 2013 Nov 13;8(11):e79721. doi: 10.1371/journal.pone.0079721. eCollection 2013.

50.

Prefabricated bone flap: an experimental study comparing deep-frozen and lyophilized-demineralized allogenic bones and tissue expression of transforming growth factor β.

Rodrigues L, dos Reis LM, Denadai R, Raposo-Amaral CE, Alonso N, Ferreira MC, Jorgetti V.

J Craniofac Surg. 2013 Nov;24(6):1914-21. doi: 10.1097/SCS.0b013e3182a41be2.

PMID:
24220373

Supplemental Content

Loading ...
Support Center